MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Local field potential changes by the patient’s conditions; 1-year follow-up of adaptive deep brain stimulation in the real world.

    H. Kamo, G. Oyama, M. Ito, H. Iwamuro, A. Umemura, N. Hattori (Tokyo, Japan)

    Objective: To evaluate changes of local field potential (LFP) in patients with Parkinson’s disease (PD) by patient conditions and overtime for one year after surgery…
  • 2023 International Congress

    The N6-Methyladenosine mRNA Methylase METTL14 Regulates TLR4-mediated intestinal dysfunction in Parkinson’s Disease

    J. Zou, Z. Deng, ZZ. Lu, L. Wei, LL. Wu, F. Yu (Guangzhou, China)

    Objective: The aim of this study is to explore the function and mechanism of RNA m6A modification in gut-derived inflammation of Parkinson's disease (PD). Background:…
  • 2023 International Congress

    Validating wearable sensors as an assessment tool for Parkinson’s Disease

    K. Silis, N. Kieran, N. Shawki, S. Madarshahian, M. Serruya, T. Liang (Philadelphia, USA)

    Objective: The objective of our pilot study was to assess the feasibility of using a portable accelerometer system to accurately identify motor findings in patients…
  • 2023 International Congress

    Protein X: a key player in Parkinson’s Disease pathophysiology? – insights from compound screening in gba1 knock-out medaka

    E. Nakanishi, T. Taguchi, N. Uemura, H. Yamakado, R. Takahashi (Kyoto, Japan)

    Objective: This experiment was conducted to elucidate the molecular pathogenesis of Parkinson's disease (PD) and identify potential treatments. Background: PD is one of the most…
  • 2023 International Congress

    Characterisation of OFF-Time in Levodopa-Treated Parkinson’s Patients: A Post-hoc Analysis of an Exploratory Trial

    J. Ferreira, W. Poewe, O. Rascol, F. Stocchi, A. Antonini, J. Moreira, B. Guimarães, J-F. Rocha (Lisbon, Portugal)

    Objective: This analysis aims to study the evolution of OFF and ON patterns during a 12-hour daily period in patients with Parkinson’s disease (PD) and…
  • 2023 International Congress

    PSP-like phenotype triggered by STN DBS in PD: a case report

    W-H. Chang, Y-C. Chen, P-L. Chen, P-H. Tu, C-H. Yeh, T-C. Liu, C-S. Lu, C-C. Chen (Taoyuan, Taiwan)

    Objective: We report on a patient with Parkinson’s disease (PD) who developed reversible Progressive Supranuclear Palsy (PSP) like phenotype after bilateral subthalamic nuclear (STN) deep…
  • 2023 International Congress

    Neuroprotective effects of oral consumption of Bifidobacterium lactis and Lactobacillus acidophilus probiotics on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropytide-induced Parkinson’s Disease mouse model

    C. Mo, Y. Qian, Y. Zhang, X. He, Y. Lai, S. Xu, P. Ai, X. Yang, Q. Xiao (Shanghai, China)

    Objective: To explore the effects of probiotics strains Bifidobacterium animalis subsp. lactis (B.lactis) and Lactobacillus acidophilus (L.acidophilus) on the inflammation of gut-brain axis and degeneration…
  • 2023 International Congress

    The association between perceived walking difficulties and gait speed in people with drug naïve/early PD

    SB. Jonasson, M. Lindh-Rengifo, E. Stomrud, O. Hansson, MH. Nilsson (Lund, Sweden)

    Objective: To investigate the association between perceived walking difficulties and gait speed in people with drug naïve or early Parkinson’s disease (PD). Background: Objective aspects…
  • 2023 International Congress

    Development and Evaluation of a Digital Resource Library for Arkansans with Parkinson Disease and Their Caregivers

    S. Dhall, A. Diamond, T. Virmani, R. Sloan, T. Burrow, J. Chacko, C. Fullen, T. Reckling, J. Holton, H. Pickett, H. Petersen, K. Coleman, D. Mcclendon, D. Chandler, E. Echols, C. Gauss, K. Donovan, S. Parveen, R. Dhall (Little Rock, USA)

    Objective: To develop and evaluate impact of a Digital Resource Library (DRL) to address unmet needs for disease state education of People with PD (PwP)…
  • 2023 International Congress

    Correlations between bradykinesia and acoustic speech variables in advanced Parkinson’s Disease

    F. Cavallieri, G. Di Rauso, A. Gessani, C. Budriesi, V. Fioravanti, S. Contardi, E. Menozzi, S. Pinto, E. Moro, F. Antonelli, F. Valzania (Reggio Emilia, Italy)

    Objective: To find the presence of possible correlations between upper extremity bradykinesia and speech variables in different medication conditions in a cohort of advanced Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 229
  • 230
  • 231
  • 232
  • 233
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley